Skip to main content
. 2014 Jun 6;9(6):e98824. doi: 10.1371/journal.pone.0098824

Table 1. Characteristics of patients with myositis-associated ILD.

Total PM-ILD DM-ILD CADM-ILD
Number of patients 114 30 41 43
Age, yrs 56 (49, 65) 54.5 (48, 62) 59 (51.5, 67.5) 56 (49, 64)
Sex, female 75 (65.8) 15 (50.0) 28 (68.3) 32 (74.4)
Time of ILD onset
Before PM/DM/CADM onset 22 (19.3) 4 (13.3) 16 (39.0) 2 (4.7)
Concomitant with PM/DM/CADM 66 (57.9) 19 (63.4) 19 (46.4) 28 (65.1)
After PM/DM/CADM onset 26 (22.8) 7 (23.3) 6 (14.6) 13 (30.2)
Form of ILD
Acute/subacute 59 (51.8) 14 (46.7) 22 (53.7) 23 (53.5)
Chronic 55 (48.2) 16 (53.3) 19 (46.3) 20 (46.5)
Signs
Dyspnea during effort 66 (57.9) 17 (56.7) 25 (61.0) 24 (55.8)
Cough 73 (64.0) 22 (73.3) 23 (56.1) 28 (65.1)
Fever 59 (51.8) 17 (56.7) 24 (58.5) 18 (41.9)
Arthralgia 52 (45.6) 15 (50.0) 21 (51.2) 16 (39.0)
Fine crackles 98 (86.0) 24 (85.7) 35 (94.6) 39 (95.1)

Data are presented as the medians (interquartile ranges) or n (%).

ILD: interstitial lung disease; PM: polymyositis; DM: dermatomyositis; CADM: clinically amyopathic dermatomyositis.